Sign In
Buy BEAT
$0.710
-0.0495 (-6.52%)
At Close: Jun 22, 2026
Heartbeam Stock Jumps After AI Collaboration With Mount Sinai
09:33am, Tuesday, 10'th Mar 2026
The collaboration will combine HeartBeam's patented ECG platform with Mount Sinai's artificial intelligence and clinical expertise to develop and validate advanced AI-ECG algorithms.
HeartBeam and Mount Sinai Announce Strategic AI Collaboration to Bring Clinical-Grade Heart Monitoring into the Home
07:00am, Tuesday, 10'th Mar 2026
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam and Mount Sinai Announce Strategic AI Collaboration to Bring Clinical-Grade Heart Monitoring into the Home.
SANTA CLARA--(BUSINESS WIRE)--HeartBeam to Attend Investor and Industry Conferences in March.
HeartBeam Announces First Patient Enrollments in Heart Attack Detection Pilot Study
07:00am, Thursday, 05'th Mar 2026
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Announces First Patient Enrollments in Heart Attack Detection Pilot Study.
HeartBeam to Host Fourth Quarter Full Year 2025 Results Conference Call on Thursday, March 12, 2026 at 4:30 p.m. Eastern Time
04:01pm, Wednesday, 04'th Mar 2026
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Host Fourth Quarter Full Year 2025 Results Conference Call on Thursday, March 12, 2026 at 4:30 p.m. Eastern Time.
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Announces First Commercial Customer as ClearCardio Brings Groundbreaking 12-Lead ECG Technology to High-Growth Preventive Cardiology Market.
HeartBeam Appoints Bryan Humbarger as Chief Commercial Officer
07:00am, Thursday, 22'nd Jan 2026
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Appoints Bryan Humbarger as Chief Commercial Officer.
HeartBeam to Attend JP Morgan 2026 Annual Healthcare Conference
07:00am, Monday, 05'th Jan 2026
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Attend JP Morgan 2026 Annual Healthcare Conference.
BEAT Secures FDA Nod for First Cable-Free At-Home 12-Lead ECG System
08:21am, Thursday, 11'th Dec 2025
HeartBeam's FDA clearance for its cable-free at-home 12-lead ECG marks a pivotal step toward commercialization and broader cardiac-care adoption.
Why Is Micro Cap HeartBeam Stock Surging On Wednesday?
11:27am, Wednesday, 10'th Dec 2025
HeartBeam, Inc.'s (NASDAQ: BEAT) stock is trading higher on Monday, with a session volume of 193.38 million compared to the average volume of 2.191 million as per data from Benzinga Pro.
HeartBeam Receives FDA Clearance for First-Ever, Cable-Free Synthesized 12-Lead ECG for At-Home Arrhythmia Assessment
07:00am, Wednesday, 10'th Dec 2025
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Receives FDA Clearance for First-Ever, Cable-Free Synthesized 12-Lead ECG for At-Home Arrhythmia Assessment.
What's Behind HeartBeam's Over 40% After-Hours Surge?
01:37am, Thursday, 27'th Nov 2025
HeartBeam shares jumped 40.75% in after-hours trading after the company outlined its regulatory strategy following the FDA's Not Substantially Equivalent decision.
HeartBeam Provides Update on Regulatory Path Following FDA Decision on 12-Lead ECG Synthesis Software Application
04:32pm, Wednesday, 26'th Nov 2025
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Provides Update on Regulatory Path Following FDA Decision on 12-Lead ECG Synthesis Software Application.
HeartBeam, Inc. (BEAT) Q3 2025 Earnings Call Transcript
08:01pm, Thursday, 13'th Nov 2025
HeartBeam, Inc. ( BEAT ) Q3 2025 Earnings Call November 13, 2025 4:30 PM EST Company Participants Robert Eno - CEO, Chief Business Officer & Director Timothy Cruickshank - Chief Financial Officer Conf
HeartBeam Reports Third Quarter 2025 Results
04:01pm, Thursday, 13'th Nov 2025
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Reports Third Quarter 2025 Results.
